Seropositivity of Toxoplasmosis in Antenatal Women with Bad Obstetric History in a Tertiary-care Hospital of Andhra Pradesh, India by Sarkar, Munmun Das et al.
©INTERNATIONAL CENTRE FOR DIARRHOEAL
DISEASE RESEARCH, BANGLADESH
Correspondence and reprint requests should be 
addressed to:
Dr. Munmun Das Sarkar 
Ideal Apartment, Flat 2D, Block A 
152 Raja R.L. Mitra Road
Kolkata 700 010, West Bengal
India 
Email: drmdsarkar@hotmail.com
Seropositivity of Toxoplasmosis in Antenatal  
Women with Bad Obstetric History in a  
Tertiary-care Hospital of Andhra Pradesh, India
Munmun Das Sarkar1, B. Anuradha2, Neelam Sharma2, and Rabindra Nath Roy1
1Burdwan Medical College, Burdwan, West Bengal, India and 2Mamata Medical College, Khammam, Andhra Pradesh, India
ABSTRACT
Toxoplasmosis is a well-documented cause of bad obstetric history (BOH) and a major reason of con-
genitally-acquired infection. The study was conducted to determine the seropositivity of toxoplasmosis in 
women with BOH, attending the antenatal clinic of the Mamata General Hospital, Khammam, Andhra 
Pradesh, India. The study subjects included 105 antenatal women with BOH and 105 antenatal women 
who had previous normal deliveries. A serological evaluation was carried out to determine the presence of 
Toxoplasma gondii-specific IgG and IgM antibodies, using commercial diagnostic kits, by the enzyme-linked 
immunosorbent assay method. The seropositivity for Toxoplasma was 49.52% in the study group compared 
to 12.38% in the control group. The difference in seropositivity was significant (p=0.00). The seroprevalence 
gradually increased with advancing age. Abortion (51.92%) was the commonest form of pregnancy wast-
age, followed by stillbirths (36.53%) and premature deliveries (7.69%). The seropositivity of toxoplasmosis 
was significantly higher in the study group than that in the control group, and the seropositivity played an 
important role in determining the foetal outcome. Considering the subclinical pattern of infection, routine 
serological test is recommended for all pregnant women for both IgG and IgM antibodies.
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INTRODUCTION
Toxoplasmosis is caused by an obligate intracellular 
protozoan parasite Toxoplasma gondii (1). It is one of 
the most common parasitic infections of humans 
and other warm-blooded animals. Approximately 
one-third of the population are exposed to this par-
asite (2). Infection in an immunocompetent adult 
human is usually asymptomatic. Toxoplasmosis is 
most dangerous for immunocompromised patients 
and the foetus whose mother is infected during 
pregnancy (3).
Transmission of the infection to the foetus usually 
occurs when primary infection is acquired by an 
immunologically-normal mother during gestation 
(4). Infected pregnant women are often asympto-
matic or many have only mild symptoms, mak-
ing the diagnosis difficult (1,3). The organism is 
transmitted haematogenously to the placenta. 
When this occurs, infection may be transmitted 
to the foetus transplacentally or during vaginal 
delivery (4). The risk of congenital toxoplasmosis 
depends on the timing of the mother’s acute infec-
tion. The disease is usually severe when acquired in 
the first trimester, and the severity decreases as the 
gestational age advances, leading to a mild or an 
inapparent disease at birth. The different rates of 
transmission and outcomes are most likely related 
to placental blood-flow, the virulence and amount 
of T. gondii acquired, and the immunologic ability 
of the mother to restrict parasitaemia (4). The over-
all rate of transmission of maternal infection to the 
foetus is about 45%. Of these, 60% are subclinical 
infections, 9% resulting in death of the foetus, and 
30% have severe damage (5). 
The clinical implications of infection due to Toxo-
plasma in pregnant patients are manifold. Such pa-
tients may have spontaneous abortions, stillbirths, 
intrauterine growth retardation, preterm deliveries, 
or foetal anomalies (6).  
Various manifestations of congenital infection may 
occur in the perinatal period. These range from rela-
tively-mild signs, such as prematurity, peripheral Sarkar MD et al.
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retinal scars, sensory deficits, developmental delay, 
impaired psychomotor performance, and mental 
retardation to the classic triad of signs consisting 
of hydrocephalus, intracerebral calcification, and 
chorioretinitis (4,7).  
Toxoplasmosis is, thus, a significant risk factor for 
bad obstetric outcome and a major cause of con-
genitally-acquired infection, leading to a high 
degree of intrauterine foetal death and morbidity 
of the newborn. Treatment of a pregnant woman 
who acquires infection at any time during preg-
nancy reduces the chance of congenital infection 
in her infant by approximately 60% (4). Therefore, 
early diagnosis of toxoplasmosis is essential to start 
appropriate treatment on time to reduce the trans-
placental transmission.
Toxoplasmosis is usually diagnosed by serological 
tests for Toxoplasma-specific IgM and IgG antibod-
ies. A positive IgG titre is sufficient to establish 
that a patient has been infected with T. gondii but 
a negative IgM result virtually rules out a recently-
acquired infection, unless sera are tested so early 
when an antibody response has not yet developed 
or is undetectable (2).
Against this background, we attempted to deter-
mine the extent of seropositivity of toxoplasmo-
sis in antenatal women with bad obstetric history 
(BOH) and to compare it with that in antenatal 
women having previous normal obstetric history, 
attending the antenatal clinic of a tertiary-care hos-
pital in Khammam, Andhra Pradesh, India. 
MATERIALS AND METHODS
Study area
This descriptive case-control study was conducted 
in 2007 at the antenatal clinic of the Mamata 
General Hospital which is a super-specialty rural 
hospital attached to the Mamata Medical College, 
Khammam, Andhra Pradesh, India. 
Study subjects
The study group comprised antenatal women of 
reproductive age with previous BOH, including 
unfavourable foetal outcome in terms of abortions, 
intrauterine foetal death, stillbirths, preterm deliv-
eries, unexplained early neonatal death, and con-
genital anomalies. The control group comprised 
multiparous, age-matched antenatal women with-
out BOH attending the same clinic.
Sample-size
To work out the required sample-size for the deter-
mination of seropositivity in antenatal women with 
BOH, the equation suggested by Vaughan and Mor-
row was used (8). Considering 49.47% seropositivi-
ty of toxoplasmosis in women with BOH (6), 10% 
margin of sampling error, and 1% non-response 
rate, the desired sample-size was 105. About 2,210 
pregnant women attended the antenatal clinic of 
the hospital in the previous year. Of these women, 
125 presented with BOH. Considering the admis-
sion trend, the investigators expected to obtain the 
desired sample within 10 months. In total, 210 
women  were  included  in  the  study―105  with 
BOH (study group) and 105 without BOH (control 
group).
Collection of data
The designated investigators visited the outpatient 
department on alternate day, selected the study 
subjects, and screened them using a predesigned 
pretested schedule considering the inclusion and 
exclusion criteria till 105 study subjects could be 
identified. The next available age-matched multipa-
rous antenatal woman without BOH was included 
in the control group subjects. 
Clinical examination and laboratory investigations 
were carried out for the study subjects to exclude 
other causes of foetal wastage, such as hyperten-
sion, diabetes mellitus, syphilis, Rh (rhesus) incom-
patibility, physical causes of abortion, and con-
sanguinity. Subjects with known causes of foetal 
wastage were excluded from the study. All of them 
were interviewed to ascertain age, medical and ob-
stetric information.
For serological analysis, 2 mL of venous blood was 
collected in a sterile container with strict aseptic 
precautions from each study subject. The serum 
was separated and stored in numbered aliquots at 
-20 oC till assayed. All the serum samples collected 
from the study and control groups were tested for 
Toxoplasma IgM and IgG antibodies by commer-
cially-available (ELISA) kits (98% sensitivity, 98% 
specificity) (Equipar Diagnostici, via G. Ferrari, 
21/N 21047 Saronno (Va), Italy). The results were 
read by a Microwell reader and compared in a par-
allel manner with controls; optical density was read 
at 450 nm on an ELISA reader.
Analysis of data
Collected data were compiled in Microsoft Excel 
spreadsheet. The proportion and the mean value 
were computed in appropriate situations. To find 
out any association between categorical data, chi-
square test was employed using the Epi Info soft-
ware (version 3.5.1).
Ethical approval
The ethical committee of the concerned institute 
approved the research protocol. The purpose and Sarkar MD et al. Toxoplasmosis and pregnancy
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Table 2. Seropositivity in relation to age of subjects
Age (years)
Study group Control group
z and 
p value  Sera tested
Positive sera 
Sera tested
Positive sera 
No.            % No.            %
≤20 12  3            25.00 7  0             0.00 0.60 (0.27)
21-25 26 10           38.46 46  5            10.86 0.89 (0.18)
26-30 39 22           56.41 35  5            14.28 2.56 (0.00)
>30 28 17           60.71 17  3            17.64 2.04 (0.02)
procedures of the study were explained to all the 
study subjects, and informed consent was obtained 
from them.
RESULTS
Seropositivity among study and control 
groups 
Table 1 shows that 49.52% were seropositive cas-
es in the study group and 12.38% in the control 
group. The seropositivity of IgG alone was ob-
served in 27.61% and 9.52% of the study and the 
control group subjects respectively. In the study 
group, 21.9% of the subjects were positive for both 
IgG and IgM antibodies while it was 2.86% in the 
control group. None was positive for IgM antibody 
alone. The difference in seropositivity was signifi-
cant (p=0.00). 
Table 1. Seropositivity among study and control groups*
Group No. of cases
No. (%) of cases 
positive for IgG 
only
No. (%) of cases 
positive for both IgG 
and IgM
Total no. (%) of 
seropositive cases
Study 105 29 (27.61) 23 (21.9) 52 (49.52)
Control 105 10 (9.52) 3 (2.86) 13 (12.38)
*None of the subjects was positive for IgM only in both the groups; Odds ratio=6.94; χ²=33.89 
(among total seropositive cases); df=1, p=0.00; df=Degree of freedom
Seropositivity in relation to age of subjects 
The seropositivity was analyzed in relation to the 
age of the study subjects (Table 2). It was observed 
that  the  seropositivity  increased  with  advancing 
age in both the groups. The seropositivity rate var-
ied from 25% to 60.71% in the study group and 
from 0% to 17.64% in the control group. The z-test 
was applied to examine the significance of differ-
ence in the proportion of seropositivity between 
the two groups. The differences were not signifi-
cant for the age-group of up to 25 years; however, 
the differences were significant for the age-groups 
of above 25 years.
Seropositivity in relation to number of bad 
obstetric outcome 
The seropositivity of Toxoplasma in relation to the 
number of times the antenatal woman experi-
enced BOH revealed that the highest percentages 
(52.38%) of positivity was noted among women 
with a history of two BOH, followed by 50% posi-
tivity among women with three or more BOH, and 
the lowest (47.27%) among women having one 
BOH (Table 3). The difference was not significant 
(p=0.88). 
Seropositivity in relation to type of bad  
obstetric history 
The seropositive cases were distributed in relation 
to the type of BOH (Table 4). It revealed that abor-
tion (51.92%) was the commonest form of preg-
nancy wastage, followed by stillbirths (36.53%), 
premature deliveries (7.69%), congenital anomalies 
(1.93%), and early unexplained neonatal deaths 
(1.93%).
DISCUSSION
Toxoplasmosis is a zoonotic disease with world-
wide distribution. Most Toxoplasma-associated in-
fections among people occur by ingesting tissue 
cysts from infected meat or oocysts from soil or by 
congenital transmission through the placenta. The 
seropositivity levels vary widely in different regions 
of the globe. The rates of prevalence change accord-
ing to the nutritional factors, sociocultural habits, 
geographic factors, climate, and transmission route 
and typically rise with age (9). 
Interpretation of Toxoplasma serology was done ac-
cording to Burrow and Duffy (10); when a positive 
IgM test result indicates acute/early infection, IgG 
titres should be retested in several weeks. A posi-
tive IgG titre is sufficient to establish that a patient 
has been infected with T. gondii. Recent infection is Sarkar MD et al.
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Table 3. Seropositivity in relation to number of bad obstetric outcomes
No. of times with bad 
obstetric outcome
No. of 
sera tested
 Seropositive
No.                %
 Seronegative 
No.              %
1 55 26               47.27 29             52.72 
2 42 22               52.38 20             47.61
3 and more 8 4                50.00 4              50.00
χ²=0.25; p=0.88; df=1; df=Degree of freedom
indicated by a positive test result for both IgG and 
IgM, and remote infection is usually indicated by a 
negative IgM with the positive IgG test result.
The prevalence of this infection reported in differ-
ent studies in India shows a wide variation, and 
one pilot study on women in Kumaon region in 
1991 reported the prevalence of 77%, the highest 
reported so far in India (11). A recent pilot study 
in the same region in 2005 reported 55% for Toxo-
plasma IgG antibodies and 20% for IgM antibodies 
(12). Singh et al. found an overall anti-Toxoplasma 
IgG seroprevalence of 45% among pregnant wom-
en in New Delhi (13).
We analyzed the odds ratio (6.94) to estimate the 
risk of adverse pregnancy outcome associated with 
exposures to toxoplasmosis. This suggests a possi-
ble causal relationship between T. gondii-associated 
infection and BOH. In our study, the overall sero-
prevalence of toxoplasmosis was 49.52% among 
antenatal women with BOH compared to 12.38% 
in the control group (Table 1). The compatible sero-
positivity of 49.47% in the study group and 8.88% 
in the control group was reported by Zargar et al. 
(6).  Borkakoty et al. reported the seroprevalence of 
44.6% and 36.8% among the study and the control 
group respectively (14). However, Singh and Dang-
vela observed an overall incidence of 13.3% in the 
study group and 4.0% in the control group (15). 
Results of a study by Bachhiwal et al. showed that 
the overall seroprevalence of toxoplasmosis was 
22% (55/250) among study subjects. In the control 
group, it was 2% (1/50). The difference was also sig-
nificant (16).
In the present study, 27.61% of the women were 
positive for IgG only, indicating remote infection, 
and 21.9% were positive for both IgG and IgM, in-
dicating recent infection. A similar result was re-
ported from a study in Hyderabad in 2001. Of 13 
serum samples screened, the positivity for IgG was 
43.3%, and the positivity for both IgG and IgM 
was 32% (17). The same investigators performed 
another similar study in 2004 and analyzed 100 
serum samples, which revealed that 33%, 5%, and 
18.2% of samples were positive for IgG, IgM, and 
both IgG and IgM respectively (18). A study in Ma-
nipur also recorded the seropositivity of 58.14% for 
IgG, 2.32% for IgM, and 6.97% for both IgG and 
IgM (19).
In the control group of the present study, the sero-
positivity of IgG, indicating remote infection, was 
9.52%, and it was 2.86% for both IgG and IgM, 
indicating recent infection (Table 1). Sandhu et 
al. detected 8% IgG seropositivity among antena-
tal women without BOH, and none of them was 
positive for IgM (20). Borkakoty et al. also observed 
the IgG seroprevalence of 36.8% among pregnant 
women without history of pregnancy wastage; in 
addition, the IgM seroprevalence was 5.9% among 
the same group (14). 
The percentage of seropositivity of toxoplasmo-
sis demonstrated a gradual increase with advanc-
ing age of the mother, and the percentage was the 
highest among women of age-group of >30 years in 
our study (Table 2). Spalding et al. also observed a 
higher prevalence among people aged 20-30 years, 
and the prevalence of infection was increasing with 
older age-group (21). Mittal et al. opined that the 
seropositivity of Toxoplasma increases with age. Ac-
cording to their study, the lowest rate of antibody 
acquisition occurred in the age-group of 15-20 
years; it increased with the increase in age; and the 
maximum prevalence was observed among women 
aged 36 years and above (22). Borkakoty et al. have 
also shown that the higher prevalence of infection 
due to T. gondii was associated with increase in age 
(14). This may be due to the fact that the frequency 
of infection increases with older age-groups as the 
probability of an individual coming into contact 
Table 4.  Seropositivity in relation to type of 
bad obstetric history
Type of bad 
obstetric history
Seropositive
(n=52)
%
(n=52)
Abortion 27 51.92
IUFD/stillbirth 19 36.53
Premature delivery 
Abortion and 
congenital defects* 
4
1
7.69
1.93
  Unexplained neonatal 
  death                                    1                1.93
*First pregnancy–abortion and second preg- 
nancy–congenitally-malformed  liveborn  baby; 
IUFD=Intrauterine foetal deathSarkar MD et al. Toxoplasmosis and pregnancy
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with the transmission routes increases as his or her 
age increases (21).
In the present study, the percentage of seropositivity 
was also assessed in relation to the number of BOH. 
Table 3 clearly shows that there was no relation-
ship between increase in the number of pregnancy 
wastages and seropositivity. This corroborates the 
observation of Borkakoty et al. (14). According to 
their study, the increase in the number of preg-
nancy wastages had no significant association with 
infection due to T. gondii (14). Women of childbear-
ing age, with no previous exposure to Toxoplasma, 
are at a risk of acquiring acute infection during 
pregnancy, resulting in congenital toxoplasmosis 
(3). Women give birth to children with congenital 
infection only once (23). If the mother was infected 
by the parasite before the current pregnancy, babies 
do not suffer from congenital toxoplasmosis. Trans-
placental transmission from chronic infection does 
not occur (1).
Among the seropositive cases, abortion (51.92%) 
was the commonest form of pregnancy wastage, 
followed by stillbirths/intrauterine foetal deaths 
(36.53%), premature deliveries (7.69%), congenital 
anomalies (1.93%), and early unexplained neona-
tal deaths (1.93%). Surpam et al. observed abor-
tions in 27.27%, intrauterine growth restriction in 
9.37%, intrauterine foetal death in 17.64%, and 
preterm labour in 18.18% of cases (24). Kandle et 
al. reported similar results in their study; 42 
(50%) abortion cases were positive for anti-Toxo- 
plasma antibodies (25). The result also partially 
matched with the observations of Bachhiwal et al. 
who reported that abortion was the commonest 
(85.45%) form of pregnancy wastage, followed by 
congenital anomalies, stillbirths, and premature 
deliveries (16). However, the observation differed 
from that of Saxena et al. According to them, posi- 
tivity was maximum in cases with history of con- 
genital malformations (33.3%), followed by cases 
with history of premature labour, abortions, and 
stillbirths (26). As such, the seroprevalence of 
toxoplasmosis was observed more among patients 
with BOH. Rai from Nepal examined 273 patients 
with various medical ailments and found that, of 
different groups, women with BOH had the highest 
seropositivity of Toxoplasma  (27).
Limitations 
Several potential limitations should be considered 
in interpreting the results of the present study. 
First, this is a hospital-based study in a rural set-up, 
which may not be representative of and applicable 
to the general population. Second, due to some con-
strains, we could not perform the IgG avidity test, 
which is needed to differentiate between acute/
recent and past infections in cases showing sero-
positivity for both IgM and IgG. Moreover, this is 
the first study on toxoplasmosis from this area. No 
previous data were available for reference. It can, 
however, provide a clear snapshot of the current 
situation, provide a reasonably precise and reliable 
estimate of the magnitude of risk, and may help 
improve the management and design of future 
studies to explore further. 
Conclusions
The present study is directed at providing the pro-
file of the seroprevalence of toxoplasmosis among 
antenatal women with and without BOH among 
the study subjects from Khammam, Andhra 
Pradesh, India. The findings revealed that the sero-
positivity of toxoplasmosis was significantly higher 
in the study group than that in the control group. 
There was a gradual increase in seroprevalence with 
advancing age, and the maximum seroprevalence 
was observed in the age-group of >30 years. The 
maximum seropositivity was observed in abortion 
cases.
The results indicate that toxoplasmosis is quite 
prevalent in and around Khammam. It is a well-
documented risk factor for BOH and may play a 
vital role in determining the foetal outcome. As 
the majority of acquired infections are subclinical, 
there is a need for regular screening of all pregnant 
women for this infection. The initiation of judi-
cious treatment in time can, thus, be provided to 
prevent morbidity and mortality of infants born to 
such mothers. 
Recommendations
Based on the findings of the study, we recommend 
the following steps for the appropriate manage-
ment of this health problem:
•	 Routine	serological	testing	is	to	be	advised	to	
all pregnant women with or without BOH, at-
tending the antenatal clinics for both Toxoplas-
ma-specific IgG and IgM antibodies.
•	 For	women	with	negative	results	in	both	the	
tests, information and education relating to 
preventive measures are of paramount impor-
tance because they are at a high risk of acquir-
ing a primary infection during pregnancy.
•		 Women	who	are	showing	both	IgM	and	IgG-
positive results, differentiation between recent 
infection and pre-existing infection may be 
done with the IgG avidity test and those show-
ing low avidity be treated accordingly.
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